New drug could treat patients hospitalised with COVID-19 pneumonia: Lancet study
The Hindu
The trial carried out between June 2020 and February 2021 involved patients aged over 16 with COVID-19 pneumonia either being treated on a ward or ICU at nine hospitals across the U.K.
A newly identified drug may be used to effectively treat some patients hospitalised with COVID-19 pneumonia, according to a study published in The Lancet Respiratory Medicine journal The team, including researchers from the University of Birmingham and the University of Oxford, U.K., tested namilumab— an antibody already in late-stage trials to treat rheumatoid arthritis —in patients hospitalised with COVID-19 pneumonia.
The patients were receiving 'usual' care, as well as having high levels in their blood of a marker of inflammation known as C reactive protein (CRP).
CRP levels rise when there is inflammation in the body, and elevated levels of CRP have been found to be a potential early marker to predict risk for severity of COVID-19, the researchers said.

After more-than-two-year wait, the flyover at Goripalayam junction will be commissioned on Saturday. As of now, the main arm of the new flyover, named after freedom fighter Netaji Subash Chandra Bose, will help to decongest vehicular movement from Tamukkam junction till Nelpettai junction on East Veli Street.












